Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Shock, Septic D012772 11 associated lipids
Immune Complex Diseases D007105 9 associated lipids
Conjunctivitis D003231 7 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Death, Sudden D003645 12 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Cardiomegaly D006332 31 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Brady HR et al. Chemoattractants provoke monocyte adhesion to human mesangial cells and mesangial cell injury. 1992 Kidney Int. pmid:1328754
Bensard DD et al. Platelet activating factor alters receptor-coupled function in the isolated perfused rat heart. 1992 J. Surg. Res. pmid:1328766
Domingo MT et al. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists. 1992 Lipids pmid:1328798
Wang YY and Li CL [Platelet-activating factor antagonists and asthma]. 1992 Sheng Li Ke Xue Jin Zhan pmid:1329195
Shukla SD et al. Hypersensitivity of diabetic human platelets to platelet activating factor. 1992 Thromb. Res. pmid:1329254
Shimizu T et al. Platelet-activating factor receptor and signal transduction. 1992 Biochem. Pharmacol. pmid:1329754
Rossi AG et al. The role of complement, platelet-activating factor and leukotriene B4 in a reversed passive Arthus reaction. 1992 Br. J. Pharmacol. pmid:1330163
Grigoriadis G and Stewart AG Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF. 1992 Br. J. Pharmacol. pmid:1330167
Hiraide A et al. Platelet-activating factor causes hypoketonaemia in starved rats. 1992 Clin. Sci. pmid:1330413
Nagahisa A et al. Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist. 1992 Eur. J. Pharmacol. pmid:1330589
Müller S and Nigam S Arachidonic acid release and platelet-activating factor formation by staurosporine in human neutrophils challenged with n-formyl peptide. 1992 Eur. J. Pharmacol. pmid:1330596
el-Moatassim C and Dubyak GR A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages. 1992 J. Biol. Chem. pmid:1331096
Kester M et al. Platelet-activating factor stimulates multiple signaling pathways in cultured rat mesangial cells. 1992 J. Cell. Physiol. pmid:1331121
Thivierge M and Rola-Pleszczynski M Platelet-activating factor enhances interleukin-6 production by alveolar macrophages. 1992 J. Allergy Clin. Immunol. pmid:1331218
Atochina EN et al. Systemic administration of platelet-activating factor in rat reduces specific pulmonary uptake of circulating monoclonal antibody to angiotensin-converting enzyme. 1992 Lung pmid:1331624
Valone FH Binding of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine to intact platelets and platelet membranes. 1992 Meth. Enzymol. pmid:1331707
Foster AP et al. Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro. 1992 Res. Vet. Sci. pmid:1332153
Silliman CC et al. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptor. 1992 Vox Sang. pmid:1332255
Kjeldsen L et al. Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules. 1992 Biochem. J. pmid:1332677
O'Flaherty JT et al. Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils. 1992 Biochem. J. pmid:1332696
Sieunarine K et al. Plasma levels of the lipid mediators, leukotriene B4 and lyso platelet-activating factor, in intraoperative salvaged blood. 1992 Vox Sang. pmid:1333134
Cattaneo M et al. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. 1992 Blood pmid:1333302
Selak MA Neutrophil elastase potentiates cathepsin G-induced platelet activation. 1992 Thromb. Haemost. pmid:1333649
Sun DX et al. Specific binding sites of platelet activating factor on the intact bovine cerebral microvascular endothelial cells and antagonism of drugs. 1992 Zhongguo Yao Li Xue Bao pmid:1333718
Nakamura M et al. Endotoxin transduces Ca2+ signaling via platelet-activating factor receptor. 1992 FEBS Lett. pmid:1333988
Bautista AP and Spitzer JJ Platelet activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion. 1992 Free Radic. Res. Commun. pmid:1334036
Bauldry SA et al. Activation of NADPH oxidase and phospholipase D in permeabilized human neutrophils. Correlation between oxidase activation and phosphatidic acid production. 1992 J. Biol. Chem. pmid:1334083
Schrör K and Felsch A Ramiprilat prevents PAF-induced myocellular and endothelial injury in a neutrophil-perfused heart preparation. 1992 Agents Actions Suppl. pmid:1334351
Clark GD et al. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. 1992 Neuron pmid:1334422
Menegazzi R et al. A new, one-step assay on whole cell suspensions for peroxidase secretion by human neutrophils and eosinophils. 1992 J. Leukoc. Biol. pmid:1334501
Bochkov VN et al. Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca(2+)-mobilizing activity of low density lipoproteins. 1992 Atherosclerosis pmid:1334652
Qian C et al. Increased platelet-activating factor (PAF) concentrations in hearts and lungs of Pichinde virus-infected guinea pigs. 1992 J Lipid Mediat pmid:1334721
Kudolo GB and Harper MJ Pregnancy-associated remodeling of rabbit endometrial platelet-activating factor receptors. 1992 J Lipid Mediat pmid:1334722
Burgers JA and Akkerman JW Effect of platelet agonists on the binding of platelet-activating factor to human platelets. 1992 J Lipid Mediat pmid:1334723
Kadiri C et al. Guinea-pig treatment with pertussis toxin suppresses macrophage-dependent bronchoconstriction by fMLP and fails to inhibit the effects of PAF. 1992 Br. J. Pharmacol. pmid:1334747
Tashiro K et al. Effects of PAF on excitatory neuro-effector transmission in dog airways. 1992 Br. J. Pharmacol. pmid:1334755
Tanimoto Y et al. Effects of cytokines on human basophil chemotaxis. 1992 Clin. Exp. Allergy pmid:1334781
Sargeant P et al. Calcium influx evoked by Ca2+ store depletion in human platelets is more susceptible to cytochrome P-450 inhibitors than receptor-mediated calcium entry. 1992 Cell Calcium pmid:1334809
Chao W et al. Protein tyrosine phosphorylation and regulation of the receptor for platelet-activating factor in rat Kupffer cells. Effect of sodium vanadate. 1992 Biochem. J. pmid:1335232
Hii CS et al. Basal and phorbol-ester-stimulated turnover of phosphatidylcholine in HeLa cells involve different pathways. 1992 Biochem. J. pmid:1335237
Müller S and Nigam S Enhancement by staurosporine of platelet-activating factor formation in N-formyl peptide-challenged human neutrophils is mediated by intracellular platelet-activating factor binding sites. 1992 Biochem. Biophys. Res. Commun. pmid:1335246
Camussi G et al. Porins and lipopolysaccharide stimulate platelet activating factor synthesis by human mesangial cells. 1992 Kidney Int. pmid:1335527
Ahmed AS and Smith SK The endometrium: prostaglandins and intracellular signalling at implantation. 1992 Baillieres Clin Obstet Gynaecol pmid:1335852
Wissner A et al. Analogues of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAF. 1992 J. Med. Chem. pmid:1336052
Hayes JP et al. Attenuation of platelet-activating factor induced bronchoconstriction by nedocromil sodium. 1992 Eur. Respir. J. pmid:1336735
Scappaticci E et al. Platelet-activating factor in bronchoalveolar lavage from patients with sarcoidosis. 1992 Am. Rev. Respir. Dis. pmid:1336939
Smith IL and Smith EA Inhibition of PAF-induced activation of human platelets by verapamil. 1992 Blood Coagul. Fibrinolysis pmid:1336985
Watanabe T [Metabolism and action mechanisms of eicosanoids and platelet-activating factor in the kidney]. 1992 Nippon Rinsho pmid:1337118
Doucet JP and Bazan NG Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma. 1992 Mol. Neurobiol. pmid:1337456
Walker BA and Ward PA Priming and signal transduction in neutrophils. 1992 Sep-Oct Biol. Signals pmid:1339178